UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CXCL10 can inhibit endothelial cell proliferation independently of CXCR3

PloS one, 2010-09, Vol.5 (9), p.e12700-e12700

2010

Volltextzugriff (PDF)

Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36

The Journal of experimental medicine, 2009-03, Vol.206 (3), p.637-653

2009

Volltextzugriff (PDF)

Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria

Proceedings of the National Academy of Sciences - PNAS, 2008-03, Vol.105 (12), p.4814-4819

2008

Volltextzugriff (PDF)

Kynurenic Acid Triggers Firm Arrest of Leukocytes to Vascular Endothelium under Flow Conditions

The Journal of biological chemistry, 2009-07, Vol.284 (29), p.19189-19195

2009

Volltextzugriff (PDF)

Intracellular Domains of CXCR3 That Mediate CXCL9, CXCL10, and CXCL11 Function

The Journal of biological chemistry, 2004-07, Vol.279 (29), p.30219-30227

2004

Volltextzugriff (PDF)

Drug product attributes predict clinical efficacy in betibeglogene autotemcel gene therapy for β-thalassemia

Molecular therapy. Methods & clinical development, 2023-12, Vol.31, p.101155-101155, Article 101155

2023

Volltextzugriff (PDF)

CXCR3 Requires Tyrosine Sulfation for Ligand Binding and a Second Extracellular Loop Arginine Residue for Ligand-Induced Chemotaxis

Molecular and Cellular Biology, 2006-08, Vol.26 (15), p.5838-5849

2006

Volltextzugriff (PDF)

Acute Myeloid Leukemia Case after Gene Therapy for Sickle Cell Disease

The New England journal of medicine, 2022-01, Vol.386 (2), p.138-147

2022

Volltextzugriff (PDF)

Betibeglogene Autotemcel Gene Therapy for Non–β0/β0 Genotype β-Thalassemia

The New England journal of medicine, 2022-02, Vol.386 (5), p.415-427

2022

Volltextzugriff (PDF)

Oligomerization of CXCL10 Is Necessary for Endothelial Cell Presentation and In Vivo Activity

Journal of Immunology, 2006-11, Vol.177 (10), p.6991-6998

2006

Volltextzugriff (PDF)

iAIDS: HIV-Related Internet Resources for the Practicing Clinician

Clinical infectious diseases, 2010-10, Vol.51 (7), p.813-822

2010

Volltextzugriff (PDF)

Mouse CCL8, a CCR8 agonist, promotes atopic dermatitis by recruiting IL-5+ T(H)2 cells

Nature immunology, 2011-02, Vol.12 (2), p.167

2011

Volltextzugriff (PDF)

Membrane‐bound eotaxin‐3 mediates eosinophil transepithelial migration in IL‐4‐stimulated epithelial cells

European Journal of Immunology, 2006-10, Vol.36 (10), p.2700-2714

2006

Volltextzugriff (PDF)

Future Directions and Resource Needs for National Heart, Lung, and Blood Institute (NHLBI) Gene Therapy Research: A Report of an NHLBI Workshop

Human gene therapy, 2023-02, Vol.34 (3-4), p.83-89

2023

Volltextzugriff (PDF)

Movement within and movement beyond: Synaptotagmin-mediated vesicle fusion during chemotaxis

Cell adhesion & migration, 2011-01, Vol.5 (1), p.56-58

2011

Volltextzugriff (PDF)

Adiponectin Inhibits the Production of CXC Receptor 3 Chemokine Ligands in Macrophages and Reduces T-Lymphocyte Recruitment in Atherogenesis

Circulation research, 2008-02, Vol.102 (2), p.218-225

2008

Volltextzugriff (PDF)

Betibeglogene Autotemcel Gene Therapy for Non-β 0 /β 0 Genotype β-Thalassemia

The New England journal of medicine, 2022-02, Vol.386 (5), p.415-427

2022

Volltextzugriff (PDF)

Synaptotagmin-mediated vesicle fusion regulates cell migration

Nature immunology, 2010-06, Vol.11 (6), p.495-502

2010

Volltextzugriff (PDF)

The Safety and Antiviral Activity of BZF961 with or without Ritonavir in Patients Infected with Hepatitis C Virus: A Randomized, Multicenter Trial

Clinical therapeutics, 2018-09, Vol.40 (9), p.1567-1581.e4

2018

Volltextzugriff (PDF)

Inhibition of Gαi2 Activation by Gαi3 in CXCR3-mediated Signaling

The Journal of biological chemistry, 2007-03, Vol.282 (13), p.9547-9555

2007

Volltextzugriff (PDF)

A Diacylglycerol Transferase 1 Inhibitor Is a Potent Hepatitis C Antiviral in Vitro but Not in Patients in a Randomized Clinical Trial

ACS infectious diseases, 2017-02, Vol.3 (2), p.144-151

2017

Volltextzugriff (PDF)

Randomized, controlled pharmacokinetic and pharmacodynamic evaluation of albinterferon in patients with chronic hepatitis B infection

Journal of gastroenterology and hepatology, 2015-01, Vol.30 (1), p.184-191

2015

Volltextzugriff (PDF)

A first-in-human, randomized, double-blind, placebo-controlled, single and multiple ascending oral dose study to assess the safety, tolerability, and pharmacokinetics of BZF961 with and without ritonavir in healthy adult volunteers

Journal of drug assessment (London, U.K.), 2018, Vol.7 (1), p.66-74

2018

Volltextzugriff (PDF)

Acute Myeloid Leukemia Case after Gene Therapy for Sickle Cell Disease

The New England journal of medicine, 2022-01, Vol.386 (2), p.138-147

2022

Volltextzugriff (PDF)

Development of a novel chemokine-mediated in vivo T cell recruitment assay

Journal of immunological methods, 2008-02, Vol.331 (1), p.127-139

2008

Volltextzugriff (PDF)

1 – 25 von 422

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(301)
Mit Volltextzugriff
(332)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(158)
Life Sciences & Biomedicine
(143)
Humans
(112)
Female
(67)
Biological And Medical Sciences
(60)
Male
(54)
Medical Sciences
(46)
Animals
(44)
Adult
(41)
Middle Aged
(38)
Mice
(29)
Education
(19)
Aged
(18)
Fundamental And Applied Biological Sciences. Psychology
(16)
Immunology
(16)
Oncology
(16)
Abdomen
(14)
Biochemistry & Molecular Biology
(14)
Cell Biology
(14)
Surgery
(14)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

The New England Journal Of Medicine
(41)
Blood
(20)
Phi Delta Kappan
(16)
Education Next
(11)
Education Week
(11)
Fortune
(10)
Transplantation And Cellular Therapy
(10)
Intensive Care Medicine
(9)
The School Administrator
(7)
State Legislatures
(6)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

CXCL10 can inhibit endothelial cell proliferation independently of CXCR3

Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36

Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria

Kynurenic Acid Triggers Firm Arrest of Leukocytes to Vascular Endothelium under Flow Conditions

Intracellular Domains of CXCR3 That Mediate CXCL9, CXCL10, and CXCL11 Function

Drug product attributes predict clinical efficacy in betibeglogene autotemcel gene therapy for β-thalassemia

CXCR3 Requires Tyrosine Sulfation for Ligand Binding and a Second Extracellular Loop Arginine Residue for Ligand-Induced Chemotaxis

Acute Myeloid Leukemia Case after Gene Therapy for Sickle Cell Disease

Betibeglogene Autotemcel Gene Therapy for Non–β0/β0 Genotype β-Thalassemia

Oligomerization of CXCL10 Is Necessary for Endothelial Cell Presentation and In Vivo Activity

iAIDS: HIV-Related Internet Resources for the Practicing Clinician

Mouse CCL8, a CCR8 agonist, promotes atopic dermatitis by recruiting IL-5+ T(H)2 cells

Membrane‐bound eotaxin‐3 mediates eosinophil transepithelial migration in IL‐4‐stimulated epithelial cells

Future Directions and Resource Needs for National Heart, Lung, and Blood Institute (NHLBI) Gene Therapy Research: A Report of an NHLBI Workshop

Movement within and movement beyond: Synaptotagmin-mediated vesicle fusion during chemotaxis

Adiponectin Inhibits the Production of CXC Receptor 3 Chemokine Ligands in Macrophages and Reduces T-Lymphocyte Recruitment in Atherogenesis

Betibeglogene Autotemcel Gene Therapy for Non-β 0 /β 0 Genotype β-Thalassemia

Synaptotagmin-mediated vesicle fusion regulates cell migration

The Safety and Antiviral Activity of BZF961 with or without Ritonavir in Patients Infected with Hepatitis C Virus: A Randomized, Multicenter Trial

Inhibition of Gαi2 Activation by Gαi3 in CXCR3-mediated Signaling

A Diacylglycerol Transferase 1 Inhibitor Is a Potent Hepatitis C Antiviral in Vitro but Not in Patients in a Randomized Clinical Trial

Randomized, controlled pharmacokinetic and pharmacodynamic evaluation of albinterferon in patients with chronic hepatitis B infection

A first-in-human, randomized, double-blind, placebo-controlled, single and multiple ascending oral dose study to assess the safety, tolerability, and pharmacokinetics of BZF961 with and without ritonavir in healthy adult volunteers

Acute Myeloid Leukemia Case after Gene Therapy for Sickle Cell Disease

Development of a novel chemokine-mediated in vivo T cell recruitment assay

Suchergebnisse filtern